 Oxidative Phosphorylation
"Oxidative Phosphorylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds.
| Descriptor ID |
D010085
|
| MeSH Number(s) |
G02.111.665.550 G03.295.631 G03.796.550
|
| Concept/Terms |
Oxidative Phosphorylation- Oxidative Phosphorylation
- Phosphorylation, Oxidative
- Oxidative Phosphorylations
- Phosphorylations, Oxidative
|
Below are MeSH descriptors whose meaning is more general than "Oxidative Phosphorylation".
Below are MeSH descriptors whose meaning is more specific than "Oxidative Phosphorylation".
This graph shows the total number of publications written about "Oxidative Phosphorylation" by people in this website by year, and whether "Oxidative Phosphorylation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 2000 | 0 | 2 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 2 | 2 | | 2011 | 1 | 1 | 2 | | 2012 | 1 | 4 | 5 | | 2013 | 2 | 3 | 5 | | 2015 | 2 | 1 | 3 | | 2016 | 3 | 4 | 7 | | 2017 | 1 | 5 | 6 | | 2018 | 2 | 7 | 9 | | 2019 | 0 | 7 | 7 | | 2020 | 1 | 4 | 5 | | 2021 | 0 | 6 | 6 | | 2022 | 0 | 3 | 3 | | 2023 | 1 | 2 | 3 | | 2024 | 2 | 4 | 6 | | 2025 | 2 | 8 | 10 | | 2026 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Oxidative Phosphorylation" by people in Profiles.
-
Meng X, Elajnaf T, Rostom H, Ma M, Furst A, Davies BR, Honess IR, Pandey G, Furigo IC, Doig CL, Martin Carli JF, Thakker RV, Bode L, Johnson KE, Hannan FM. Insulin resistance is associated with mammary mitochondrial dysfunction at the onset of human lactation. J Clin Invest. 2026 Oct 15; 136(20).
-
Huerta Arana M, Klapproth H, Stanczak MA, Bopp L, Witschurke K, Seitz R, Lopéz Martinez M, Zamek J, Henschke S, Rana N, O'Sullivan D, Steinkamp J, Lackmann JW, Damsky W, von Stebut E, Sanin DE, Zigrino P, Klein Geltink RI, Pearce EJ, Pearce EL, Fabri M. A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease. Sci Adv. 2026 May 29; 12(22):eaea0773.
-
Zhao W, Chrisenberry DB, Varela M, Luna-Ramirez RI, Anderson MJ, Langlais PR, Brown LD, Limesand SW. Correction of hypoxemia and hypoglycemia restores muscle mitochondrial respiration and remodels mitochondrial proteome in growth-restricted sheep fetuses. Am J Physiol Endocrinol Metab. 2026 Jun 01; 330(6):E774-E781.
-
Sonti S, Leek C, Lingappan K. Modulation of alveolar macrophages by sex as a biological variable. Am J Physiol Lung Cell Mol Physiol. 2026 05 01; 330(5):L530-L538.
-
Ling T, O'Brien C, St-Germain JR, Rondeau V, Shi M, Berman JM, Cepa A, Saez Raez P, Wunderlich M, Carter KM, Stillwell C, Sexton C, Culp-Hill R, Reisz JA, Adeel SA, Zeng AGX, Bansal S, Tsao E, Chen HT, Dick JE, Minden MD, Arruda A, Amaya ML, Tikhonova AN, Hope KJ, D'Alessandro A, Raught B, Jones CL. Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation. Blood. 2026 Feb 19; 147(8):863-876.
-
Sessions DT, Boulton DP, Spoelstra NS, Caino MC, Yu M, Goodspeed A, Richer JK. Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer. Endocrinology. 2025 Dec 05; 167(1).
-
Shimada H, Sakuragi T, Barentsen K, Erickson K, Urschitz J, Powell TL, Jansson T, Rosario FJ. Placental mitochondrial respiration is inhibited in mice with trophoblast specific AdipoR2 overexpression. Free Radic Biol Med. 2026 Feb 01; 243:276-290.
-
Friederich MW, Van Hove JLK. Clinical utility of the ATP hydrolysis assay for the diagnosis of complex V deficiency in cultured skin fibroblasts. Mol Genet Metab. 2025 Nov; 146(3):109257.
-
Peters H, Fung CM, Dettman RW, Dizon MLV, Chang J. Metabolic Reprogramming of Oligodendrocytes in Intrauterine Growth Restriction. Dev Neurosci. 2026; 48(5):379-397.
-
Fielder SM, Friederich MW, Hock DH, Zhang JR, Valin LM, Rosenfeld JA, Booth KTA, Brown NJ, Rius R, Sharma T, Semcesen LN, Worley KC, Burrage LC, Treat K, Samson T, Govert S, DaCunha S, Yuan W, Chen J, Lesinski J, Hoang H, Morrison SA, Ladha FA, Van Hove RA, Michel CR, Reisdorph R, Tycksen E, Baldridge D, Silverman GA, Soler-Alfonso C, Conboy E, Vetrini F, Emrick L, Craigen WJ, Sykes SM, Stroud DA, Van Hove JLK, Schedl T, Pak SC. Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disorders. EMBO Mol Med. 2025 10; 17(10):2562-2585.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|